glp-1 tracker and Health Journey Template You can also track your weight Pep vs. Lose It!: Which

All SGLT2i CVOTs carried out to date have demonstrated a consistent risk reduction for heart failure-related hospitalizations in patients with established CV disease or high CV risk

Our Medical Team determines which medication is clinically -appropriate for you

Once you start feeling better, moving your body becomes easier

Both Saxenda and Wegovy are covered by the NHS for patients that fulfill certain criteria of BMI and/or weight-related comorbidity

Side effects and treatment experience can vary by individual

Both medications operate by simulating incretin hormones that govern appetite and insulin production, yet Mounjaros dual-receptor action delineates a novel path in appetite and glucose level management